Antigenicity and Immunogenicity of the V3 Domain of HIV Type 1 Glycoprotein 120 Expressed on the Surface of Streptococcus gordonii

No abstract is available for this paper.

• Publication year

  1999

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/088922299311204PMID 10195755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

  2009cited by this paper
• Expression of active monomeric and dimeric nuclease A from the gram-positive Streptococcus gordonii surface protein expression system.

  2000cited by this paper
• Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

  1999cited by this paper
• Attenuated Listeria monocytogenescarrier strains can deliver an HIV‐1 gp120 T helper epitope to MHC class II‐restricted human CD4+ T cells

  1998cited by this paper
• Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens.

  1998cited by this paper
• Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.

  1998cited by this paper
• Comparison of the Abilities of Different AttenuatedSalmonella typhimurium Strains To Elicit Humoral Immune Responses against a Heterologous Antigen

  1998cited by this paper
• Vaginal Immunization with Recombinant Gram‐Positive Bacteria

  1998cited by this paper
• Why do we not have an HIV vaccine and how can we make one?

  1998cited by this paper
• Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice.

  1997cited by this paper
• Recombinant Streptococcus gordonii as a Live Vehicle for Vaccine Antigens

  1997cited by this paper
• Expression of Vaccine Antigens in Lactobacillus

  1997cited by this paper
• Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences

  1997cited by this paper
• Role of cellular immunity in protection against HIV infection.

  1997cited by this paper
• Induction of Mucosal and Systemic Responses against Human Immunodeficiency Virus Type 1 Glycoprotein 120 in Mice after Oral Immunization with a Single Dose of a Salmonella-HIV Vector

  1997cited by this paper
• 27 – Rectal and Genital Immunization with SIV/HIV

  1996cited by this paper
• Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

  1996cited by this paper
• A host-vector system for heterologous gene expression in Streptococcus gordonii.

  1996cited by this paper
• Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.

  1995cited by this paper
• Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.

  1995cited by this paper
• Immunization of mice by oral colonization with live recombinant commensal streptococci.

  1995cited by this paper
• Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.

  1994cited by this paper
• Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers.

  1993cited by this paper
• Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41.

  1993cited by this paper
• Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens

  1992cited by this paper
• Delivery and expression of a heterologous antigen on the surface of streptococci

  1992influential reference
• Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion.

  1992cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

  1991cited by this paper
• Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

  1991cited by this paper
• Immunogenicity and antigenicity of conserved peptides from the envelope of HIV-1 expressed at the surface of recombinant bacteria.

  1990cited by this paper
• An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

  1989cited by this paper

• A review on edible vaccines and their prospects

  2020cites this paper
• Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors

  2015cites this paper
• Surface Display of Aeromonas hydrophila GAPDH in Attenuated Vibrio anguillarum to Develop a Noval Multivalent Vector Vaccine

  2011cites this paper
• The oral commensal, Streptococcus gordonii, synergizes with Tat protein to induce HIV-1 promoter activation in monocytes/macrophages.

  2011cites this paper
• Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

  2009cites this paper
• Primary Activation of Antigen-Specific Naive CD4+ and CD8+ T Cells following Intranasal Vaccination with Recombinant Bacteria

  2008cites this paper
• Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

  2008cites this paper
• Systemic and mucosal immunity to respiratory syncytial virus induced by recombinant Streptococcus gordonii surface-displaying a domain of viral glycoprotein G.

  2006cites this paper
• Stimulation of Human Monocytes with the Gram-Positive Vaccine Vector Streptococcus gordonii

  2006cites this paper
• In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii

  2006cites this paper
• Oral immunization of BALB/c mice by intragastric delivery of Streptococcus gordonii-expressing Giardia cyst wall protein 2 decreases cyst shedding in challenged mice.

  2006influential citation
• Oral immunizationof BALB/cmice by intragastricdeliveryof Streptococcusgordonii -expressingGiardia cystwall protein2 decreases cyst shedding in challengedmice

  2006influential citation
• Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes.

  2006cites this paper
• Selection and characterization of a promoter for expression of single-copy recombinant genes in Gram-positive bacteria

  2005cites this paper
• Characterization and applications of Lactobacillus brevis S-layer proteins and evaluation of Lactococcus lactis as a porcine cytokine producer

  2005cites this paper
• Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism

  2005cites this paper
• Protective immunity of SpaA‐antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection

  2004cites this paper
• Thermal stability of vaccines.

  2003cites this paper
• Amylase-binding proteins A (AbpA) and B (AbpB) differentially affect colonization of rats' teeth by Streptococcus gordonii.

  2003cites this paper
• Lactic Acid Bacteria as Mucosal Delivery Vehicles

  2003cites this paper
• Genetically modified lactic acid bacteria: applications to food or health and risk assessment.

  2002cites this paper
• Lactobacilli as live vaccine delivery vectors: progress and prospects.

  2002cites this paper
• Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C

  2002cites this paper
• The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1

  2002cites this paper
• Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface.

  2002cites this paper
• Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants

  2002cites this paper
• HIV Vaccines Design and Development

  2002cites this paper
• Biotechnological Approaches to Fight Pathogens at Mucosal Sites

  2001cites this paper
• Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.

  2001cites this paper
• Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.

  2001cites this paper
• Elicitation of predictable immune responses by using live bacterial vectors.

  2001cites this paper
• Recombinant Streptococcus gordonii for Mucosal Delivery of a scFv Microbicidal Antibody

  2001cites this paper
• Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii.

  2001cites this paper
• Rational development of prophylactic HIV vaccines based on structural and regulatory proteins.

  2001cites this paper
• Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS.

  2000cites this paper
• Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii

  2000cites this paper
• Live bacterial delivery systems for development of mucosal vaccines.

  2000cites this paper
• Expression of measles virus antigens in Streptococcus gordonii.

  2000cites this paper
• Expression of active monomeric and dimeric nuclease A from the gram-positive Streptococcus gordonii surface protein expression system.

  2000cites this paper
• Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.

  1999cites this paper
• Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

  1999cites this paper
• Non-Invasive Vaccine Delivery System: A Review

  year unknowncites this paper